Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (1111-1120 of 22,015) with videos related to

Pageof 2,202
Sort By:
Oncogene|September 13, 2022
Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotypeSynat Kang, Lixin Wang, Lu Xu, et al.
Oncogene|September 10, 2022
Transgenic construction and functional miRNA analysis identify the role of miR-7 in prostate cancer suppressionCan Wang, Wenchao Li, Qiang Hu, et al.
Oncogene|September 10, 2022
The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinomaTheodore Evan, Victoria Min-Yi Wang, Axel Behrens
Oncogene|December 15, 2021
p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundanceLuis Coronel, David Häckes, Katjana Schwab, et al.
Oncogene|January 11, 2022
Targeting HIF-1α/NOTCH1 pathway eliminates CD44<sup>+</sup> cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinomaJoo-Yun Byun, Kun Huang, Jong Suk Lee, et al.
Oncogene|January 3, 2022
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibitionWanting Han, Mingyu Liu, Dong Han, et al.
Oncogene|January 2, 2022
CD147 supports paclitaxel resistance via interacting with RanBP1Gang Nan, Shu-Hua Zhao, Ting Wang, et al.
Oncogene|January 1, 1987
Induction of transiently expressed genes in PC-12 pheochromocytoma cellsD A Kujubu, R W Lim, B C Varnum, et al.
Oncogene|March 13, 2021
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa BAlfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, et al.
Oncogene|March 13, 2021
BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repairMengdong Ni, Jiajia Li, Haiyun Zhao, et al.
Pageof 2,202

Showing results (1111-1120 of 22,015) with videos related to

Sort By:
Pageof 2,202
Oncogene|September 13, 2022
Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotypeSynat Kang, Lixin Wang, Lu Xu, et al.
Oncogene|September 10, 2022
Transgenic construction and functional miRNA analysis identify the role of miR-7 in prostate cancer suppressionCan Wang, Wenchao Li, Qiang Hu, et al.
Oncogene|September 10, 2022
The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinomaTheodore Evan, Victoria Min-Yi Wang, Axel Behrens
Oncogene|December 15, 2021
p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundanceLuis Coronel, David Häckes, Katjana Schwab, et al.
Oncogene|January 11, 2022
Targeting HIF-1α/NOTCH1 pathway eliminates CD44<sup>+</sup> cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinomaJoo-Yun Byun, Kun Huang, Jong Suk Lee, et al.
Oncogene|January 3, 2022
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibitionWanting Han, Mingyu Liu, Dong Han, et al.
Oncogene|January 2, 2022
CD147 supports paclitaxel resistance via interacting with RanBP1Gang Nan, Shu-Hua Zhao, Ting Wang, et al.
Oncogene|January 1, 1987
Induction of transiently expressed genes in PC-12 pheochromocytoma cellsD A Kujubu, R W Lim, B C Varnum, et al.
Oncogene|March 13, 2021
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa BAlfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, et al.
Oncogene|March 13, 2021
BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repairMengdong Ni, Jiajia Li, Haiyun Zhao, et al.
Pageof 2,202